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ABSTRACT  The intracellular  pathway of cartilage proteoglycan  biosynthesis was investigated 
in  isolated  chondrocytes  using  a  protein  A-gold  electron  microscopy  immunolocalization 
procedure.  Proteoglycans  contain  a  protein  core  to which  chondroitin  sulfate  and  keratan 
sulfate  chains and  oligosaccharides  are  added  in  posttranslational  processing.  Specific  anti- 
bodies  have  been  used  in this study to determine separately the distribution  of the  protein 
core and chondroitin sulfate  components.  In normal chondrocytes, proteoglycan protein core 
was readily  localized  only in smooth-membraned  vesicles  which co-labeled  with ricin,  indi- 
cating them to be galactose-rich  medial/trans-Golgi cisternae,  whereas there was only a low 
level of labeling in the rough endoplasmic reticulum. Chondroitin sulfate was also localized in 
medial/trans-Golgi cisternae of control  chondrocytes  but was not detected  in other cellular 
compartments.  In cells treated with monensin (up to 1.0/~M), which strongly inhibits proteo- 
glycan  secretion  (Burditt,  L. J., A.  Ratcliffe,  P.  R.  Fryer,  and  T.  Hardingham,  1985,  Biochim. 
Biophys. Acta., 844:247-255), there was greatly increased  intracellular localization of proteo- 
glycan protein core in both ricin-positive vesicles,  and in ricin-negative vesicles  (derived from 
cis-Golgi stacks) and in the distended  rough endoplasmic  reticulum.  Chondroitin  sulfate  also 
increased in abundance after monensin treatment, but continued to be localized only in ricin- 
positive vesicles.  The results suggested  that the synthesis  of chondroitin sulfate  on proteogly- 
can only occurs in  medial/trans-Golgi cisternae as a late event  in  proteoglycan  biosynthesis. 
This also  suggests that glycosaminoglycan  synthesis  on proteoglycans takes  place  in a com- 
partment in common with events in the biosynthesis of both o-linked and N-linked oligosac- 
charides on other secretory glycoproteins. 
Proteoglycans are a  specialized group of glycoproteins con- 
taining glycosaminoglycan chains. The aggregating proteogly- 
can  found  abundantly  in  cartilage  is  of particularly  high 
molecular weight (Mr 1 x  106-4 x  10 6) (22). It consists of a 
protein core which, when newly synthesized, has a molecular 
weight of 300,000-350,000 (34, 40, 68, 70, 74) and to which 
are attached  many chondroitin sulfate and keratan  sulfate 
chains, and both o-linked and N-linked oligosaccharides (16, 
21, 23). The protein core contains three main regions: a folded 
globular binding region, which forms a specific site for inter- 
action with hyaluronate; an adjacent region rich in keratan 
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sulfate chains; and a major extended region bearing the chon- 
droitin sulfate chains (16, 20, 23) (see Fig.  1). Proteoglycans 
are present in the extracellular matrix of cartilage as large 
aggregates in which many proteoglycans are bound to a chain 
of  hyaluronate  (19),  with  each  proteoglycan-hyaluronate 
bond being stabilized by a globular link protein (Mr 40,000) 
(4,  15, 32, 43, 61, 67). 
Proteoglycan  biosynthesis involves the synthesis of  a protein 
core and the addition to this of more than 10 times its weight 
of polysaccharide components in posttranslational processing 
(17,  18, 24, 54). Investigations of the kinetics of proteoglycan 
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FIGURE  I  Antibody  binding  sites  on 
proteoglycan. Diagram of a cartilage pro- 
teoglycan and the sites of antibody bind- 
ing after chondroitinase ABC  digestion. 
Digestion  of  the  chondroitin  sulfate 
chains  generate epitopes of  4,  6,  and 
non-sulfated chondroitin sulfate,  which 
remain attached to the protein core and 
are recognized by the monoclonal anti- 
bodies 9-A-2,  3-B-3, and 1-B-5, respec- 
tively. The binding of antibodies to bind- 
ing region is unaltered by the chondroi- 
tinase ABC digestion. 
anti-binding 
region antibodies  sulfate antibodies 
biosynthesis in rat chondrosarcoma cells showed that protein 
core synthesis was followed by a considerable delay (60-90 
min) before the addition of chondroitin sulfate chains, and 
that chondroitin sulfate synthesis was rapid and was quickly 
followed (<10  rain) by secretion (9,  30,  31,  36).  This was 
corroborated by the identification of an intracellular pool of 
protein core devoid of chondroitin sulfate chains (5, 9,  34, 
40).  Biosynthetic labeling experiments showed that only the 
N-linked  oligosaccharides were attached to the protein core 
soon after protein synthesis within  the  rough endoplasmic 
reticulum (RER) I (11,  33).  The gtycosaminoglycans and o- 
linked  oligosaccharides  were added  in  smooth  membrane 
systems (11) which appeared to be part of the Golgi complex 
(33). This supported previous evidence from autoradiography 
and immunofluorescence which showed that the perinuclear 
(Golgi) region in chondrocytes was  the major site of [35S]- 
sulfate incorporation (12,  29, 45) and of proteoglycan and 
glycosaminoglycan localization  (41,  71-73).  The  evidence 
thus suggested the pathway of proteoglycan biosynthesis to be 
similar to that of other secretory glycoproteins. 
In studies of glycoprotein and proteoglycan biosynthesis, 
monensin has been used to interfere with intracellular trans- 
location of secretory proteins in many different cell types. At 
tow concentration it inhibits transport within the Golgi com- 
plex, but does not inhibit protein synthesis (62-65). In chon- 
drocytes, it potently inhibits chondroitin sulfate synthesis on 
proteoglycans (27,  37,  39,  60) and leads  to an intracellular 
accumulation of the proteoglycan protein core (5, 39, 40). 
In the present study using electron microscopic immuno- 
localization (44,  50), the intracellular localization of proteo- 
glycan protein core and chondroitin sulfate has been deter- 
Abbreviation  used in this paper.  RER,  rough endoplasmic reticu- 
lure. 
mined in chondrocytes. Using Ricinus communis agglutinin 
I (ricin) (28) and anti-ricin antibodies (13), it has been possible 
to identify the intracellular site of  chondroitin sulfate synthesis 
on cartilage proteoglycan within Golgi subcompartments. 
MATERIALS  AND  METHODS 
Chondrocyte Cultures:  Chondrocytes were isolated from fresh pig 
laryngeal cartilage, as described previously (5).  The cartilage was digested with 
0.05%  hyaluronidase (Sigma Chemical Co.,  Poole,  England) for  30  min  at 
37"C,  for 2 h  in 0.25% collagenase (Flow Laboratories, Inc., Irvine. England) 
at 37"C,  and finally overnight in 0.1% coliagenase at 37"C.  The released cells 
were washed and plated at a density of 2 x  104 cells/35-mm tissue culture dish. 
The chondrocytes were cultured for 24 h in medium containing 10% fetal calf 
serum and for an additional 24 h  in medium containing 2% fetal calf scrum. 
The cells were then removed from the dishes by gentle agitation, resuspended 
in medium containing 2% fetal calf serum and the appropriate concentration 
of monensin (Sigma Chemical Co.).  After a  4-h  incubation, the cells were 
pelleted by centrifugation and fixed and embedded for electron microscopy. 
Antisera and Monoclonal Antibodies:  The localization  of pro- 
teoglycan protein core was with a  polyclonal antiserum directed against the 
binding region domain (43).  There  is one such domain in each aggregating 
proteoglycan, and the detection of binding region therefore reflects the distri- 
bution  of proteoglycan protein  core,  irrespective of structural  variations in 
other regions of the molecule (for example, changes in carbohydrate composi- 
tion). These antibodies have previously been used for quantitative determina- 
tion of proteoglycan distribution in cartilage sections by radioimmunoassay 
and electron microscopic immunolocalization (44), and the antiserum was used 
at a  1:5 dilution. The antiserum to ricin was a gift from Drs. Graham Warren 
and Daniel Louvard (European Molecular Biological Laboratories, Heidelberg, 
Federal Republic of Germany) and was as previously described and was used 
at a dilution of 1:100 (13). 
The monoclonal antibodies to chondroitin sulfate (9-A-2, 3-B-3,  and I-B-5) 
were a gift from Dr. Bruce Caterson (University of West Virginia, Morgantown, 
VA) and were as previously described (6).  They recognize unsaturated deter- 
minants on 4, 6, and non-sulfated chondroitin sulfate, respectively, and these 
epitopes are generated by chondroitinase ABC digestion and remain attached 
to  proteoglycan,  one on  each  chondroitin  sulfate chain residue (Fig.  1).  A 
mixture of all three antibodies was used in order to maximize the detection of 
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on the results. The final dilution of each monoclonal  antibody was 1:50. 
Electron Microscopy  and Immunolocalization:  For standard 
morphological studies, chondrocytes were fixed in 3% glutaraldehyde in 0. l M 
sodium cacodylate buffer, pH 7.4, for 2 h at room temperature,  postfixed in 
1% osmium tetroxide in the same buffer, dehydrated  in graded acetone, and 
embedded  in Spurt resin. Sections were cut using a diamond knife, mounted 
on copper grids, and stained with aqueous uranyl acetate and Reynold's  lead 
citrate. 
The electron microscopic immunolocalization  used a post-embedding tech- 
nique (44) with protein A-gold as the immunolabel.  The cells were fixed in 1% 
glutaraldehyde in 0.1 M phosphate buffer, pH 7.2, for 2 h at room temperature, 
and  embedded  in  Lowicryl  K4M  embedding  resin  (Agar  Aids,  Stanstead, 
England) using modifications  described by Fryer et al. (10) of the method  of 
Roth et al. (50). The immunolocalization  procedure  was carried out on the 
surface of ultrathin  sections mounted on parlodion-coated  nickel grids. Colloi- 
dal gold of 18-nm diameter was prepared using trisodium  citrate (l) and of 4- 
nm diameter using white phosphorus  (56). Complexes of protein A (Pharmacia 
Fine Chemicals,  Sweden) with gold were prepared  as described by Slot and 
Geuze (56). 
The  single immunolabeling  procedure  was as described  previously  (44). 
Nonspecific background labeling was minimized by preincubating the sections 
in 1% bovine serum albumin/phosphate-buffered  saline (BSA/PBS) for 30 rain. 
The  sections  were  then  digested  with  chondroitinase  ABC  at  0.5  U/ml  -~ 
(Worthington  Biochemical Corp., Millipore, England) for 45 rain at 37"C (44), 
washed (three times) with 1% BSA/PBS for 5 rain, incubated with an antibody 
dilution  for 2 h, and then washed as before and incubated with protein A-gold 
for l h. The sections were finally washed three times with PBS and then rinsed 
in a stream of  distilled water, lightly stained with uranyl acetate and lead citrate, 
and viewed in a JEOL 1200 EX electron microscope. With the anti-chondroitin 
sulfate mouse monoclonal antibodies ( l-B-5 and 3-B-3), a second l-h antibody 
incubation  with rabbit  anti-mouse  IgG was included  before incubation  with 
protein A-gold since they bind only weakly to protein A. Immunolabeling with 
ricin  (Sigma Chemical  Co.) and anti-ricin  antiserum  was carried  out as de- 
scribed by Griffiths et at. (13). After the sections had been incubated with  1% 
BSA/PBS and digested with chondroitinase  ABC, they were incubated  with 
ricin (50 t~g/ml  -~) for 30 min, stream washed with PBS, and then washed with 
1% BSA/PBS, and incubated for 30 min with the anti-ricin antiserum.  Double- 
immunolabeling  experiments using protein  A-gold of two different sizes were 
performed  essentially  as described  by  Roth (48). The first immunolabeling 
procedure  was as described  above  but using 4-nm diameter  protein  A-gold 
particles. This procedure was then repeated on the same section to localize the 
second antigen  but this time using the  18-nm protein  A-gold  particles. The 
antibody  dilutions  used  were  selected  by  titration  of the  antibodies  in  an 
immunolocalization  experiment.  The concentration  of antibody  selected was 
that which gave high specific labeling with  low background  labeling. Small 
variations in the concentrations  used did not affect the level of  labeling achieved. 
The density of labeling over different cellular compartments (nucleus, mi- 
tochondria,  Golgi  region,  RER,  and  cytoplasm)  was determined  from four 
experiments  in which a minimum of 30 cells per concentration  of monensin 
was examined.  The distribution  of each antigen  amongst smooth membrane 
(Golgi) vesicles was determined by counting the number of  smooth-membraned 
vesicles per cell, the proportion of these vesicles that contained protein A-gold, 
and the number of gold particles per vesicle. The labeling of Golgi vesicles was 
assessed including all labeling clearly associated with the vesicle. Where labeling 
was present  over the  more electron-dense  margins  of the vesicles, this  was 
included in the area assessed. These results were obtained from a minimum of 
four experiments  in which 50-120  cells were examined. The quantitative  data 
shown for single label experiments were obtained using 18-nm diameter protein 
A-gold.  The distribution  of labeling  in  both the single- and double-labeled 
experiments was independent  of gold particle size, although in general more of 
the smaller gold particles were bound per unit area. 
Control  experiments  using (a) non-immune rabbit serum or (b) 1% BSA/ 
PBS showed no localized labeling in untreated  or monensin-treated  chondro- 
cytes and the  average density  of protein  A-gold over the  cells was <2 gold 
particles/urn 2 (Fig. 2). 
The density of label within each compartment for each treatment  of  the cells 
was analyzed by Wilcoxon Paired  Rank Sum Tests on all  available pairs. P 
values larger than 0.005 were considered as not significant. The density of label 
in each compartment was compared between normal, and 0.1 #M and 1.0 uM 
monensin-treated cells using one-way analysis of variance. 
RESULTS 
Normal Chondrocytes 
The  chondrocytes  in  culture  showed  a  normal  general 
FIGURE 2  Chondrocyte embedded in  Lowicryl  k4M  resin,  non- 
immune serum control. A chondrocyte section incubated with non- 
immune rabbit serum followed by protein A-gold (18-nm diameter) 
as an immunolabeling  control. This section shows Golgi region (G), 
RER (R), mitochondria (M), nucleus (N), and plasma membrane (P). 
There is no localized labeling and  the density of protein A-gold 
over the cells is low (<2 gold particles//~m2).  Bar, 1.0 #m. x  22,200. 
morphology (Fig.  3,  a  and b).  Sections embedded  in  Spun" 
resin showed abundant RER and Golgi stacks  composed of 
flattened cisternae closely apposed to each other. Planimetric 
determinations showed the RER to occupy more than nine 
times  the volume  of the smooth  membrane  Golgi compo- 
nents.  Previous experiments  showed  the cells  to  synthesize 
and  secrete  into  the  medium  the  aggregating  chondroitin 
sulphate proteoglycan typical of cartilage  (5). 
To identify the intracellular compartments containing pro- 
teoglycan  at  different  stages  of biosynthesis,  Lowicryl-em- 
bedded sections  of chondrocytes were  incubated with  anti- 
bodies to specific proteoglycan components, followed by lo- 
calization  with  protein  A-gold.  Preliminary  experiments 
showed localization in Spurr-embedded non-osmicated tissue 
to be unsuccessful and low-temperature Lowicryl K4M resin 
was thus chosen as it gave good ultrastructural  preservation 
together with  efficient  immunocytochemical  labeling (2,  3, 
44,  50) which was also appropriate for quantitative analysis 
(2, 44). 
IMMUNOLOCALIZATION  OF  PROTEOGLYCAN  PRO- 
TEIN  CORE:  When  antiserum  to  the  binding  region  of 
proteoglycan was used to localize the protein core, the labeling 
was not abundant, but occurred mainly over the Golgi region 
and in membrane-bound secretory vesicles (Fig.  4) (5). The 
distribution was similar to that we had previously observed 
in chondrocytes within articular  cartilage  (44). Quantitative 
evaluation of the distribution of the protein A-gold (Table I) 
RATCLIFFE ET  At.  IntracellularLocalizationofProteoglycans  2357 FIGURE .3  Chondrocytes treated with various concentrations of monensin and embedded in Spurt resin. (a) Control chondrocyte 
showing Golgi stacks (G), RER (R), mitochondria (M), nucleus (N), plasma membrane (P), and centriole (C). x  17,000. (b) Control 
chondrocyte at  higher magnification (x  39,000)  showing typical Golgi stacks (arrows). (c)  Chondrocyte treated with 0.1  /~M 
monensin showing some  distended cisternae  of the Golgi stacks (arrows).  x  29,000.  (d) Chondrocyte treated with  1.0 #M 
monensin showing a large number of distended vesicles (arrowheads), and condensed mitochondria (arrows). x  13,000. Bars, (a, 
c, and d) I  /~m and (b) 0.5 #m. 
2358  THE  JOURNAL OF  CELL BIOLOGY • VOLUME  101, 1985 FIGUP,  ES 4-7  Chondrocytes  embedded in Lowicryl k4M resin, and proteoglycan  protein core, medial/trans-Golgi,  and chondroitin 
sulfate localized  with protein A-gold. (Fig. 4) Chondrocytes showing a low density of labeling  of protein core in the Golgi complex 
(18-nm diameter protein A-gold). (Fig. 5) Golgi stack in a chondrocyte labeled with ricin and anti-ricin antibodies followed by 
protein A-gold (18-nm diameter). The immunolabel binds to cisternae and vesicles only on one side of the stack, indicating these 
to be the medial/trans-Golgi compartments,  with the unlabeled cisternae being on the cis side of the Golgi stack. (Fig. 6) Golgi 
stack in a chondrocyte double-labeled for ricin (4-nm  diameter protein A-gold) and protein core (18-nm diameter protein A- 
gold). The immunolabel for ricin and protein core co-localize, and are present only on one side of the Golgi stack. (Fig. 7) Golgi 
stack in a chondrocyte labeled for chondroitin sulfate (4-nm diameter protein A-gold). The label is seen only on one side of the 
Golgi stack. Bars, 5, 0.5, 0.25, and 0.I 25 p.m, respectively,  x  25,000, 67,500, 100,000, and 136,000, respectively. TAmE  I.  Density of Protein A-Gold Labeling of Proteoglycan Protein Core Over Cellular Compartments (Gold Particles/#m  2 +_ 5£)). 
Golgi region*  RER  Nucleus  Mitochondria  Cytoplasm 
Control  35.0_+  18.8  7.2 +  3.7  2.4_  1.5  5.1  _  4.1  2.3 _  1.1 
Monensin (0.1  ~M)  48.2 _+ 28.0  9.8 _  3.6  2.0 +_ 0.8  2.0 _  1.9  1.8 +  0.8 
Monensin (1 .O ~M)  60.1  _  26.0  13.8 _+ 8.3  2.4 +_ 1.5  2.5 +  4.1  2.0 _+ 0.9 
The density of label for binding region in the untreated and monensin-treated cells over the Golgi region and RER was significantly different from each other 
and from all other compartments (P <  0.0001) except RER versus mitochondria in untreated cells (P >  0.05).  The density of label in the nucleus, cytoplasm, 
and mitochondria was not significantly different from each other (P >  0.05).  Comparison of each subcellular compartment in normal, and in 0.1 /~M and 1.0 
#M monensin-treated cells showed a significant increase in the density of label in the Golgi region (P =  0.0006) and RER (P =  0.0007) of treated cells,  but 
there was no significant difference in the other compartments (P >  0.1). 
* All smooth-membraned vesicles. 
TABLE II.  Single-Label  Experiments 
Labeled vesicles (% of total) 
Binding  Chondroitin 
region  Ricin  sulfate 
Control  50  50  50 
Monensin (0.1  /.tM)  78  46  48 
Monensin (1.0/-M)  90  47  48 
Chondrocyte sections were labeled with specific antibodies and protein A- 
gold, and the  proportion of smooth  membrane-bound  vesicles containing 
immunolabel was determined. 
TABLE III.  Double-Label Experiments  for Binding Region and Ricin* 
Labeled vesicles (% of total) 
BR-/ 
BR÷/ricin -  BR+/ricin +  ricin + 
Control  7  86  7 
Monensin (0.1  uM)  47  51  2 
Monensin (1.0/~M)  54  46  0 
* BR, binding region of proteoglycan protein core. 
confirmed this specificity of labeling, the Golgi region was the 
most densely labeled cellular compartment, and 50% of the 
vesicles were labeled (Table II). The labeling of other cellular 
compartments was low, but showed a slight increase over the 
cisternal  space of the  RER,  which  was significantly higher 
than  the  background  labeling  of nuclear  and  cytoplasmic 
compartments, but was not above that of the mitochondria. 
The general level of background labeling was similar to that 
previously  reported  using  similar  techniques  for detecting 
other intracellular antigens (2). 
IMMUNOLOCALIZATION  OF  MEDIAL  AND  TRANS- 
GOLGI ELEMENTS"  To determine the sites of protein core 
localization within the Golgi complex, ricin was used as a 
selective marker of galactose-rich membranes that are char- 
acteristic  of medial  and  trans-Golgi elements  (13).  When 
sections of chondrocytes were labeled with ricin and anti-ricin 
antibodies,  followed  by protein  A-gold,  the  immunolabel 
bound to the cisternae only on one side of the stack (Fig.  5) 
which  suggested these  to  be the  medial/trans-subcompart- 
ments and those unlabeled to be on the cis side of the Golgi 
stack (l 3). The ricin labeled 50% of the total smooth-mem- 
braned vesicles of the control cells (Table II). It also labeled 
the plasma membrane as has been previously reported (13, 
38) but other membranes including RER did not label. As a 
control, the ricin was incubated with 300 mM ~galactose for 
l 0 rain before the labeling procedure (13) and this was found 
to inhibit binding completely (density of gold particles, <2 
per um2). 
The origin of the vesicles which labeled for bingiing region 
was determined in double-label experiments in which ricin 
and  binding  region  labeling were  distinguished  using  gold 
particles of two sizes (4-nm and 18-nm diameter). In normal 
chondrocytes (Table III) a high proportion (80%) of labeled 
vesicles contained both sizes of protein A-gold (Fig. 6), indi- 
cating that proteoglycan protein  core detected was only in 
medial/trans-Golgi compartments. 
IMMUNOLOCALIZATION  OF  CHONDROITIN  SUL- 
FATE:  Evidence suggests  that the synthesis of chondroitin 
sulfate chains on the protein core occurs in the Golgi complex 
(12, 29, 41, 45, 71-73) but its precise location within some or 
all of the Golgi compartments has not previously been deter- 
mined. A mixture of monoclonal antibodies directed against 
chondroitinase  ABC-digested  residues  of 6-sulfated,  4-sul- 
fated, and non-sulfated chains was therefore used to localize 
proteoglycans bearing  chondroitin  sulfate  in  the  chondro- 
cytes. 
In  normal cells  the immunolabel for chondroitin  sulfate 
was observed only in the Golgi region, and the other cellular 
compartments including the RER did not contain label above 
background levels (Table IV). Within the Golgi region, the 
label was found in 50% of the vesicles and preferentially on 
one side of the Golgi stack (Fig. 7) (Table II). This distribution 
of the immunolabel for chondroitin sulfate on proteoglycan 
was similar to that observed for ricin labeling of the Golgi 
elements, except that the plasma membrane was not labeled. 
The origin of the vesicles containing chondroitin sulfate was 
determined with chondroitin sulfate antibodies and ricin, in 
double-labeling  experiments.  In  the  normal  chondrocytes, 
ricin and chondroitin sulfate labeling showed the same distri- 
bution with <5% of the labeled vesicles containing only one 
size of the protein A-gold (Table V). Chondroitin sulfate was 
thus shown to be present with the proteoglycan protein core 
only within the medial/trans-Golgi compartments. 
Chondrocytes  Treated with  Monensin 
In chondrocytes treated with monensin, the morphology of 
the  Golgi  complex  changed  dramatically  (5).  After  a  4-h 
incubation  with  0.1  ~M  monensin,  the  Golgi  stacks  were 
often replaced by large vesicles, probably formed by extensive 
swelling  of the Golgi cisternae (Fig.  3 c) and there was also 
dilation of some cisternae of the RER. After incubation with 
1.0  ~M  monensin,  the dilation  of the  RER  became more 
pronounced, Golgi stacks were often no longer apparent, and 
the number of smooth-membraned vesicles increased sixfold 
(Fig.  3 d). Other cellular features appeared unaltered except 
that the mitochondria were more electron dense, as previously 
reported (64). 
IMMUNOLOCALIZATION  OF  PROTEOGLYCAN  PRO- 
TE]N CORE:  Immunolocalization of binding region showed 
there to be a dose-dependent increase in the density of  labeling 
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Golgi region*  RER  Nucleus  Mitochondria  Cytoplasm 
Control  57.7 _  24.5  2.1  _  3.0  4.7 __. 3.8  8.6 +  6.7  2.9 +  2.4 
Monensin (0.1 t~M)  76.8 +_ 48.1  2.7 +  4.3  4.1  _+ 2.7  6.4 +  7.5  3.3 +_ 1.7 
Monensin (1  #M)  51.9 _  33.6  3.3 _  3.0  8.5 -4- 5.5  5.4 +  5.7  3.6 +  2.0 
In the untreated and monensin-treated cells,  the density of label for chondroitin sulfate in the Golgi region was significantly higher (P <  0.002) than in all 
other compartments, whereas the density of label in the RER was not significantly higher than any other compartment.  Comparison of the Golgi region in 
normal, and in 0.1  ~,M and 1.0 uM monensin-treated cells showed no significant change in the density of labeling (P =  0.07).  Comparison of other cellular 
compartments also showed no significant change (P >  0.01) with monensin treatment. 
"All smooth-membraned vesicles. 
TASTE V.  Double-Label Experiments for Chondroitin Sulphate and 
Ricin 
Labeled vesicles (% of total} 
CS+/  CS-/ 
ricin-  CS+/ricin +  ricin + 
Control  <5  >95  <5 
Monensin (0.1  #M)  <5  >95  <5 
Monensin (t .0 ~tM)  <5  >95  <5 
C5, chondroitin sulfate. 
of protein core within the RER (Table I, Fig.  8). There was 
also an increase in the volume of the cisternal space of the 
RER, and thus a marked accumulation of protein core within 
this  compartment.  Within  the  Golgi  region  there  was  an 
increase in the number of vesicles and also an increase in the 
percentage of vesicles containing immunolabel (Table II, Figs. 
9  and  10). The  number  of gold  particles  per  vesicle also 
increased by 15% at 0.1 tzM monensin and by 40% at 1.0 #M 
monensin,  and  this  corresponded  to  a  dose-dependent  in- 
crease in the density of labeling.  The proteoglycan protein 
core was thus  shown to accumulate along the intracellular 
pathway involved in  its biosynthesis as previously reported 
(5). 
IMMUNOLOCALIZATION  OF  MEDIAL  AND  TRANS- 
GOLG] ELEMENTS:  TO determine the origin of the vesicles 
in the Golgi complex in cells treated with monensin, sections 
were labeled with ricin and anti-ricin antibodies.  Although 
the number of vesicles per cell increased, the proportion that 
was labeled with ricin did not change significantly: 46%  of 
vesicles was labeled at 0.1  #M and 47% at 1.0 #M (Table II). 
As a  similar proportion of the  newly formed vesicles were 
labeled with ricin, it suggested that these vesicles were derived 
from both the cis- and medial/trans-Golgi cisternae. 
The origin of the vesicles that labeled for binding region in 
the monensin-treated chondrocytes was determined in dou- 
ble-label experiments for ricin and binding region. With in- 
creasing concentrations of monensin,  the percentage of la- 
beled vesicles that were double-labeled decreased from 86% 
in controls to 50% at 0.1  ~M monensin and to 46% at  1.0 
/~M monensin (Table III) (Fig.  11). This corresponded to an 
increase in the number of vesicles which labeled for binding 
region alone, which was only 7 % in control cells, but increased 
to 54% at 1.0 #M monensin. Together these results suggested 
that monensin blocked translocation within or movement out 
of the medial/trans-cisternae of the Golgi stack, producing an 
accumulation  of the  proteoglycan  protein  core  in  vesicles 
derived from both the medial/trans- and cis-Golgi elements 
in  addition  to its accumulation within  the cisternae of the 
RER. 
IMMUNOLOCALIZATION  OF  CHONDROITIN  SUL- 
FATE:  In chondrocytes treated with monensin, chondroitin 
sulfate was localized more abundantly, but the distribution of 
immunolabel remained the same as that in untreated cells. 
The immunolabel was only found in Golgi-type vesicles (Ta- 
ble IV) and the proportion of vesicles that contained label 
was similar to untreated controls being 48% at both 0.1  vM 
and  1.0  ~M monensin (Table II). Furthermore, in double- 
label experiments the ricin and chondroitin sulfate labeling 
showed the same distribution as in control cells with >95% 
of labeled  vesicles containing  both  sizes  of gold  particles 
(Table V). These results show that chondroitin sulfate is only 
detected  on  proteoglycan protein  core within  the  medial/ 
trans-Golgi elements and  not  within  cis-Golgi or RER,  at 
earlier sites along the pathway of biosynthesis. 
DISCUSSION 
Intracellular  localization  of proteoglycans in  both  normal 
cartilage (44) and isolated chondrocytes (5) with antibodies to 
the binding region showed a limited distribution within some 
Golgi cisternae and within  secretory vesicles.  In this study, 
the binding region was only detected in abundance within the 
Golgi compartment in normal chondrocytes. The failure to 
detect protein core extensively within  RER of the chondro- 
cytes may be because the concentration of antigen there is 
too low. The volume of the RER within the cells is much 
greater than that of the Golgi compartment (approximately 
ninefold) and so if the normal pathway of secretory protein 
biosynthesis involves passage from the RER through the Golgi 
compartment on a route to secretion, then the protein is likely 
to be much less concentrated within the RER than within the 
Golgi compartment. A concentration of antigen in RER as 
low as one-ninth  of that  in  the Golgi compartment might 
therefore be towards the limit of detection. It is also apparent 
that  proteoglycan accounts for only a  small  proportion  of 
total protein synthesis in chondrocytes (5)  and the labeling 
density  achieved  within  the  ricin-positive  Golgi  compart- 
ments was <20% of that detected in the pericellular matrix 
of intact cartilage (44). 
The detection of proteoglycan binding region within intra- 
cellular compartments may also have been hindered by the 
antigen's inaccessibility to the antibody within the membrane- 
bound compartments. However, this is unlikely as the local- 
ization of chondroitin sulfate within the Golgi vesicles did not 
give a much higher density of  labeling than for binding region, 
and chondroitin sulfate is unlikely to be inaccessible because 
of association with membranes as it is very hydrophilic, and 
there are many copies of the epitope on each proteoglycan 
that should facilitate its detection. Furthermore, as the anti- 
binding region antiserum used contained antibodies to both 
native  (43)  and  unfolded  structures  (Ratcliffe,  A.,  and  T. 
Hardingham, unpublished results), it is unlikely to have been 
limited by any delay in the formation of native conformations 
RATCLIFFE lET AL.  Intracellular  Localization of Proteoglycans  2361 FIGURES 8-11  Chondrocytes were treated with various concentrations  of monensin, embedded in Lowicryl k4M resin, and the 
protein core, medialltrans-Golgi,  and chondroitin sulfate localized with protein A-gold. (Fig. 8) Chondrocyte treated with 10/~M 
monensin showing labeling (18-nm  diameter protein A-gold) for binding region in  distended cisternae  of the  RER. (Fig. 9) 
Chondrocyte treated with  0.1  /~M  monensin showing the majority of vesicles labeled for binding region,  with  some of the 
immunolabel also in the distended cisternae of the RER (18-nm diameter protein A-gold). (Fig. 10) Chondrocyte treated with 1.0 
/~M monensin showing vesicles that are heavily labeled for binding region. (Fig. 11) Chondrocyte treated with 0.1 /~M monensin 
and double-labeled  for ricin (4-nm diameter protein A-gold) and binding region (18-nm diameter protein A-gold). Dilated Golgi 
cisternae can be seen, with the vesicles to the right  labeled with both ricin and binding region  (medial/trans-Golgi  region) and 
those to the left labeled for binding region alone (cis-Golgi region). Bars, (Figs. 8 and 9) 1 #m; (Fig. 10) 0.5 #m; (Fig. 11) 0.2 #m. 
x  18,000, 25,700, 38,000, and 108,000, respectively. in  the binding region  of the nascent protein core.  The low 
detection of proteoglycan protein core within the RER may 
thus be an accurate reflection of its low concentration at the 
site of protein translation. 
The  carboxylic  ionophore  monensin  interferes  with  the 
intracellular translocation of secretory proteins in many cell 
types without major inhibition of protein synthesis (14,  26, 
35, 59, 60,  63-65, 69).  In chondrocytes it has been shown to 
inhibit proteoglycan secretion and 35S incorporation (5, 40) 
and to lead to an intracellular accumulation of proteoglycan 
protein core (40) which was localized in many newly formed 
Golgi vesicles and within the distended cisternae of the RER 
(5). In the present study, the identity of the vesicles containing 
protein  core and those containing chondroitin  sulfate were 
explored using the lectin from Ricinus comrnunis which was 
shown to distinguish  medial/trans-Golgl  from cis-Golgi ele- 
ments in baby hamster kidney cells (13), and in these normal 
pig cartilage chondrocytes it showed similar selective labeling. 
The results obtained by localizing proteoglycan protein core 
and  ricin  in double-label experiments showed monensin to 
block protein core transport into the galactose-rich compart- 
ment of the medial/trans-Golgi  cisternae (Fig.  10). This is the 
same site of action as reported in baby hamster kidney cells 
(14) but present results would also suggest some inhibition of 
translocation from trans-Golgi elements into secretory vesi- 
cles (42). 
The effect of monensin  on  the  detection  of chondroitin 
sulfate was quite different. Although as with binding region it 
was only detected within  ricin-positive smooth membraned 
vesicles in normal chondrocytes, after monensin treatment it 
continued to be localized only within the same ricin-positive 
medial/trans-Golgi  vesicles.  Localization  in  chondrocytes 
treated with even low concentrations of monensin (0.1  uM) 
thus showed a clear distinction between proteoglycan protein 
core and chondroitin sulfate distribution. The failure to detect 
chondroitin sulfate outside the medial/trans-Golgi  compart- 
ment, even when protein core was very abundant in cis-Golgi 
and RER compartments, strongly suggests  the medial/trans- 
Golgi compartment to be the only site of chondroitin sulfate 
synthesis on the proteoglycan (see Fig.  12).  It also suggests 
that monensin causes no reversal of normal vectorial transfer, 
i.e., back from the medial/trans-Golgi  compartment into cis- 
Golgi and RER compartments. The high coincidence between 
the dual labeling ofchondroitin sulfate and ricin also suggests 
that  synthesis  occurs immediately on  transfer into  medial 
Golgi  elements,  before  movement into  trans  elements,  or 
throughout  the  medial/trans-Golgi  elements,  which  may 
function  as  a  single  compartment  (52,  53).  These  results 
extend recent evidence from immunofluorescence studies on 
chondroitin  sulfate synthesis (71)  which  showed,  using  the 
same anti-chondroitin sulfate antibodies as in this study, that 
chondroitin  sulfate  was  localized  in  a  perinuclear  (Golgi) 
region.  This was  supported by subcellular  fractionation  of 
chondrocytes (11), in which chondroitin sulfate synthesis was 
localized  in  smooth  membrane  (Golgi)  fractions  although 
xylosyl transferase activity has been detected more in rough 
microsomal  fractions  (25).  Vertel  and  Barkman  (71)  also 
demonstrated by immunofluorescence that chondroitin  sul- 
fate and  keratan  sulfate co-localized within  Golgi  vesicles, 
suggesting that  chondroitin  sulfate and  keratan  sulfate are 
synthesized in  the same compartment. Experiments on the 
kinetics of biosynthesis of chondroitin  sulfate and o-linked 
oligosaccharides in  chondrocytes  showed them  both  to  be 
synthesized as proteoglycan as a  late event in  intracellular 
processing (31,  33). The present results on the siting of chon- 
droitin sulfate synthesis within the medial/trans-Golgl  com- 
partments are thus entirely compatible with other evidence of 
its location. 
Although monensin strongly inhibited (80%) the incorpo- 
ration of [35S]sulfate into chondroitin sulfate in chondrocytes 
(5), this was accompanied by increased intracellular localiza- 
tion  of chondroitin  sulfate in  medial/trans-Golgl  elements. 
There  are  two  main  factors  which  may account  for  this. 
Firstly, the epitopes by which chondroitin sulfate was detected 
are generated by chondroitinase ABC digestion and occur one 
per chondroitin  sulfate chain irrespective of its initial chain 
length before digestion. Secondly, in the presence of monen- 
sin,  the length of chondroitin sulfate chains has been shown 
to be greatly reduced (37,  60).  The presence of chondroitin 
sulfate within  all  newly formed ricin-positive vesicles  after 
monensin treatment is therefore compatible with the synthesis 
of very short chondroitin sulfate chains on the proteoglycan 
that accumulated in the medial/trans-Golgi  compartment (see 
Fig.  12). The main effect of monensin in  inhibiting  chon- 
droitin  sulfate synthesis may not therefore be caused by it 
restricting the supply of protein core to the site of chondroitin 
sulfate synthesis, but by direct inhibition of chondroitin sul- 
fate  chain  elongation.  This  is  supported  by  results  which 
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FIGURE 12  Summary  of  the  immuno- 
localization of proteoglycan protein core 
and chondroitin sulfate  in the RER, cis- 
Golgi  (ricin-negative) and  medial/trans- 
Golgi  {ricin-positive]  compartments  of 
control and monensin-treated chondro- 
cytes. In control chondrocytes, low con- 
centration of protein core was detected 
in the RER, and within the Golgi region 
the protein core was detected mainly in 
the  medialltrans-Golgi  compartments, 
where chondroitin  sulfate  was also  lo- 
calized.  In  monensin-treated  cells,  se- 
cretion  of  proteoglycan  was  inhibited 
and  protein  core  accumulated  in  all 
Golgi compartments and also in the RER. 
In contrast, chondroitin sulfate remained 
restricted  to  medial/trans-Golgi  ele- 
ments. 
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ample substrate for chain elongation (46,  47),  failed to give 
much  relief to  monensin  inhibition  of chondroitin  sulfate 
synthesis in chondrocytes (37).  However, as chondroitin sul- 
fate  synthesis  requires  the transfer  of nucleotide  sugar  and 
sulfate  intermediates  from  the  cytosol into Golgi  compart- 
ments (55), one of the effects of monensin may be to inhibit 
this transfer and thereby deplete the glycosyl transferases and 
sulphotransferases  of these  substrates.  Proteoglycan  protein 
core may thus continue  to arrive in the medial/trans-Golgi 
cisternae,  but inhibition  of elongation  may lead to the pre- 
mature termination of chondroitin sulfate chains. 
In many cell  types the medial/trans-Golgj cisternae  have 
been  shown to be the site  of late  modifications  of N-linked 
oligosaccharide  synthesis  involving galactose  and sialic  acid 
transfer (7,  51, 52,  57,  66) and also a major site of o-linked 
oligosaccharide completion (8, 49, 58). As chondroitin sulfate 
co-distributed with all the galactose-rich cisternae of the me- 
dial/trans-Golgj cisternae of the chondrocytes in this study, it 
suggests that chondroitin sulfate synthesis occurs on proteo- 
glycan in a compartment in common with N-linked oligosac- 
charide  processing and o-linked oligosaccharide  completion 
on other secretory glycoproteins. This implies that proteogly- 
cans  are  not  segregated  into  a  separate  compartment  for 
glycosaminoglycan synthesis and that the selection of protein 
core for glycosaminoglycan synthesis may depend primarily 
upon the specificity  of the glycosyl transferases  involved in 
their biosynthesis. This adds to the range of glycosyl transfer- 
ase  activities  associated  with  medial/trans-Golgi compart- 
ment and suggests that it can function as a site of biosynthesis 
of all classes of o-linked carbohydrate substituents of secretory 
glycoproteins. 
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